News
April 18, 2025

Regenstrief Institute researcher departs after more than two decades of service 

Michael Weiner, MD, MPH

After more than two decades of impactful work in Indiana, Michael Weiner, M.D., MPH, is departing Regenstrief Institute, Indiana University School of Medicine and the Richard L. Roudebush Veterans Administration Medical Center in Indianapolis to continue his contributions in health services research.  

Dr. Weiner has been a key figure in advancing healthcare delivery and outcomes research through his longtime roles as a director, research scientist, professor and clinician. He served as director of the VA Health Systems Research (HSR) Center for Health Information and Communication (CHIC), a role he held for more than a decade. He served as director of the Regenstrief Center for Health Services Research from 2010 to 2019 and helped build CHIC into a nationally recognized VA research center. 

Since joining the IU School of Medicine and Regenstrief in 1999, Dr. Weiner has made significant contributions to data-driven research and clinical innovation.  

While he is stepping down from his Indiana-based roles, Dr. Weiner will continue to focus on improving health systems and patient care as he begins his next chapter at the David Geffen School of Medicine at UCLA and the VA Greater Los Angeles Healthcare System 

Michael Weiner, M.D., MPH  

In addition to his role as a research scientist with the William M. Tierney Center for Health Services Research at Regenstrief Institute, Michael Weiner, M.D., MPH, is a research scientist at the VA Health Service Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center, and a professor of medicine at Indiana University School of Medicine. 

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher